These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 23608077)
1. White matter integrity and executive abilities in individuals with phenylketonuria. Antenor-Dorsey JA; Hershey T; Rutlin J; Shimony JS; McKinstry RC; Grange DK; Christ SE; White DA Mol Genet Metab; 2013 Jun; 109(2):125-31. PubMed ID: 23608077 [TBL] [Abstract][Full Text] [Related]
2. White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria. White DA; Antenor-Dorsey JA; Grange DK; Hershey T; Rutlin J; Shimony JS; McKinstry RC; Christ SE Mol Genet Metab; 2013 Nov; 110(3):213-7. PubMed ID: 23928118 [TBL] [Abstract][Full Text] [Related]
3. Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria. Hood A; Antenor-Dorsey JA; Rutlin J; Hershey T; Shimony JS; McKinstry RC; Grange DK; Christ SE; Steiner R; White DA Mol Genet Metab; 2015 Jan; 114(1):19-24. PubMed ID: 25481106 [TBL] [Abstract][Full Text] [Related]
4. Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria. Peng H; Peck D; White DA; Christ SE J Inherit Metab Dis; 2014 Mar; 37(2):237-43. PubMed ID: 24043380 [TBL] [Abstract][Full Text] [Related]
5. White and gray matter brain development in children and young adults with phenylketonuria. Hawks Z; Hood AM; Lerman-Sinkoff DB; Shimony JS; Rutlin J; Lagoni D; Grange DK; White DA Neuroimage Clin; 2019; 23():101916. PubMed ID: 31491833 [TBL] [Abstract][Full Text] [Related]
6. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial. Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509 [TBL] [Abstract][Full Text] [Related]
7. Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria. Hood A; Rutlin J; Shimony JS; Grange DK; White DA JIMD Rep; 2017; 33():41-47. PubMed ID: 27450369 [TBL] [Abstract][Full Text] [Related]
8. Neurocognitive functioning in adults with phenylketonuria: results of a long term study. Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437 [TBL] [Abstract][Full Text] [Related]
9. Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria. Hood A; Grange DK; Christ SE; Steiner R; White DA Mol Genet Metab; 2014 Apr; 111(4):445-51. PubMed ID: 24568837 [TBL] [Abstract][Full Text] [Related]
10. Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated PKU: a DTI study of the corpus callosum. White DA; Connor LT; Nardos B; Shimony JS; Archer R; Snyder AZ; Moinuddin A; Grange DK; Steiner RD; McKinstry RC Mol Genet Metab; 2010; 99 Suppl 1(0 1):S41-6. PubMed ID: 20123469 [TBL] [Abstract][Full Text] [Related]
11. Cerebral blood flow and white matter alterations in adults with phenylketonuria. Steiner L; Muri R; Wijesinghe D; Jann K; Maissen-Abgottspon S; Radojewski P; Pospieszny K; Kreis R; Kiefer C; Hochuli M; Trepp R; Everts R Neuroimage Clin; 2024; 41():103550. PubMed ID: 38091797 [TBL] [Abstract][Full Text] [Related]
12. Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria. Christ SE; Price MH; Bodner KE; Saville C; Moffitt AJ; Peck D Mol Genet Metab; 2016 May; 118(1):3-8. PubMed ID: 26947918 [TBL] [Abstract][Full Text] [Related]
13. Inter- and intra-tract analysis of white matter abnormalities in individuals with early-treated phenylketonuria (PKU). Clocksin HE; Hawks ZW; White DA; Christ SE Mol Genet Metab; 2021 Jan; 132(1):11-18. PubMed ID: 33334682 [TBL] [Abstract][Full Text] [Related]
14. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study. Jahja R; Huijbregts SCJ; de Sonneville LMJ; van der Meere JJ; Legemaat AM; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; van Spronsen FJ Neuropsychology; 2017 May; 31(4):437-447. PubMed ID: 28318283 [TBL] [Abstract][Full Text] [Related]
15. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients. Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654 [TBL] [Abstract][Full Text] [Related]
16. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study. Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792 [TBL] [Abstract][Full Text] [Related]
17. Relationship Between DTI Metrics and Cognitive Function in Alzheimer's Disease. Mayo CD; Garcia-Barrera MA; Mazerolle EL; Ritchie LJ; Fisk JD; Gawryluk JR; Front Aging Neurosci; 2018; 10():436. PubMed ID: 30687081 [No Abstract] [Full Text] [Related]
18. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919 [TBL] [Abstract][Full Text] [Related]
19. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Diamond A; Prevor MB; Callender G; Druin DP Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921 [TBL] [Abstract][Full Text] [Related]
20. Long-term cognitive and psychosocial outcomes in adults with phenylketonuria. Aitkenhead L; Krishna G; Ellerton C; Moinuddin M; Matcham J; Shiel L; Hossain S; Kiffin M; Foley J; Skeath R; Cleary M; Lachmann R; Murphy E J Inherit Metab Dis; 2021 Nov; 44(6):1353-1368. PubMed ID: 34145605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]